Spycher M O, Nydegger U E, Luescher E F
Adv Exp Med Biol. 1984;167:241-51. doi: 10.1007/978-1-4615-9355-3_20.
Glycocalicin (Gc) is the large, water soluble fragment, obtained by cleavage of one of the major membrane glycoproteins, GP Ib, of human platelets by means of the endogenous, calcium-dependent neutral protease (CNP) obtained from lysed platelets. GP Ib has been proposed as the receptor for von Willebrand factor (vWF) as well as for the Fc-receptor of the platelet surface. We have investigated, whether Gc was involved in a receptor function for aggregated human IgG, which is a powerful activator of platelets. Neither Gc nor asialo-Gc inhibited the stimulation of human blood platelets by bisdiazoniumbenzidine-aggregated human IgG (BDB-IgG). Moreover, platelets, after treatment with a crude preparation of CNP, which removes Gc, could be stimulated by BDB-IgG as well as or better than control platelets, but were unreactive with bovine vWF. We conclude that the Gc-moiety of GP Ib, which is involved in the bovine vWF binding site, is not the Fc-receptor on platelets. Thus, the inhibition, by human or rabbit IgG aggregates or monomeric rabbit IgG, of vWF-induced platelet agglutination, as reported by other authors, is either due to a steric effect resulting from a vicinal position of both receptors or involves the residual part of GP Ib after cleavage of Gc.
糖钙蛋白(Gc)是一种大的水溶性片段,它是通过用从裂解血小板中获得的内源性钙依赖性中性蛋白酶(CNP)切割人血小板的主要膜糖蛋白之一糖蛋白Ib(GP Ib)而得到的。GP Ib被认为是血管性血友病因子(vWF)以及血小板表面Fc受体的受体。我们研究了Gc是否参与了聚集人IgG的受体功能,聚集人IgG是血小板的一种强大激活剂。Gc和去唾液酸Gc均未抑制重氮联苯胺聚集人IgG(BDB-IgG)对人血小板的刺激。此外,用去除Gc的CNP粗制品处理后的血小板,与对照血小板相比,受到BDB-IgG的刺激效果相同或更好,但与牛vWF无反应。我们得出结论,GP Ib中参与牛vWF结合位点的Gc部分不是血小板上的Fc受体。因此,如其他作者所报道的,人或兔IgG聚集体或单体兔IgG对vWF诱导的血小板凝集的抑制作用,要么是由于两种受体相邻位置产生的空间效应,要么涉及Gc切割后GP Ib的剩余部分。